CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on immunotherapy, precision medicine and neuroscience in oncology on Thursday, Dec. 12 from 6 to 9 p.m. at the Princeton Marriott at Forrestal in Princeton. The summit will be co-chaired by John Theurer Cancer Center, Hackensack Meridian Health medical experts Andre H. Goy, M.D., M.S., Martin E. Gutierrez, M.D., and Andrew L. Pecora, M.D., FACP, CPE.
Expert presenters will delve into informative topics of discussion including the following:
- The Basics of Immunotherapy presented by Dr. Pecora
- Precision Medicine presented by Dr. Goy
- Immunotherapy in Lung Cancer presented by Dr. Gutierrez
- CAR T-Cell Therapies for Hematologic Malignancies presented by Dr. Goy
State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.
Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at email@example.com.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.